Summary
The effect of bromocriptine on tritiated thymidine incorporation into nuclei of human fibroblasts has been investigated. A dose-dependent decrease of the labelling index has been found. This observation suggests that the antimitotic action of bromocriptine is a more general phenomenon not restricted to the adenohypophysial cells.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Boynton, A. L., Whitfield, J. P.: Calmodulin stimulates DNA synthesis by rat liver cells. Biochem. Biophys. Res. Commun.95, 745–749 (1980).
Kraicer, J., Spence, J. W.: Release of growth hormone from purified somatotrophs: use of high K+ and ionophore A 23187 to elucidate interrelations among Ca++, adenosine 3′ 5′ monophosphate, and somatostatin. Endocrinology108, 651–657 (1981).
Lloyd, H. M., Meares, J. D., Jacobi, J.: Effects of oestrogen and bromocriptine onin vivo secretion and mitosis in prolactin cells. Nature255, 497–498 (1975).
McGregor, A. M., Scanlon, M. F., Hall, R., Hall, K.: Effects of bromocriptine on pituitary tumor size. Brit. Med. J.2, 700–703 (1979).
Pawlikowski, M.: Attempt at pharmacological treatment of the pituitary tumor with bromocriptine. Endokrynologia Polska29, 413–416 (1978).
Pawlikowski, M., Stepień, H.: Effects of fibroblast growth factor and bromocriptine on the mitotic activity of the anterior pituitary gland in organ culture. Cell Tissue Res.202, 165–169 (1979).
Pawlikowski, M.: The link between secretion and mitosis in the endocrine glands. Life Sci.30, 315–320 (1982).
Perris, A. D., Whitfield, J. P., Tolg, P. K.: Role of calcium in the control of growth and cell division. Nature219, 527–530 (1968).
Petrini, M., Giampietro, O., Ambrogi, F.: Is bromocriptine CB 154 an antimitotic drug? Drugs Exptl. Clin. Res.7, 649–652 (1981).
Rychter, J., Stepień, H.: Effects of pimozide and bromocriptine on the proliferation of rat pituitary pars intermedia cells. J. Endocrinol.75, 443–444 (1977).
Stepień, H., Wolaniuk, A., Pawlikowski, M.: Effects of pimozide and bromocriptine on anterior pituitary cell proliferation. J. Neural Transm.42, 239–244 (1978).
Thorner, M. O., Martin, W. H., Rogol, A. D., Morris, J. L., Perrymon, R. L., Conway, B. P., Howards, S. S., Wolfman, M. G., MacLeod, R. M.: Rapid regression of pituitary prolactinomas during bromocriptine treatment. J. Clin. Endocr. Metab.51, 438–445 (1980).
Thorner, M. O., Hackett, J. T., Murad, F., MacLeod, R. M.: Calcium rather than cyclic AMP as a physiological intracellular regulator of prolactin release. Neuroendocrinology31, 390–402 (1980).
Wass, J. A. H., Moult, P. J. A., Thorner, M. O., Charlesworth, M., Jones, A. E., Besser, G. M.: Reduction of pituitary tumour size in patients with prolactinomas and acromegaly, treated with bromocriptine with or without radiotherapy. Lancet2, 66–69 (1979).
Author information
Authors and Affiliations
Additional information
This paper was supported by the Polish Academy of Sciences, grant No 10.4.04.5.
Rights and permissions
About this article
Cite this article
Pawlikowski, M., Jakubowski, L. & Kałużewski, B. The antimitotic effect of bromocriptine on human fibroblasts. J. Neural Transmission 56, 91–95 (1983). https://doi.org/10.1007/BF01243377
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01243377